Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Receivables (2016 - 2025)

Prestige Consumer Healthcare has reported Receivables over the past 15 years, most recently at $190.5 million for Q4 2025.

  • Quarterly results put Receivables at $190.5 million for Q4 2025, up 13.86% from a year ago — trailing twelve months through Dec 2025 was $190.5 million (up 13.86% YoY), and the annual figure for FY2025 was $194.3 million, up 9.91%.
  • Receivables for Q4 2025 was $190.5 million at Prestige Consumer Healthcare, down from $199.0 million in the prior quarter.
  • Over the last five years, Receivables for PBH hit a ceiling of $199.0 million in Q3 2025 and a floor of $114.7 million in Q1 2021.
  • Median Receivables over the past 5 years was $161.0 million (2023), compared with a mean of $160.1 million.
  • Biggest five-year swings in Receivables: dropped 23.82% in 2021 and later grew 21.68% in 2025.
  • Prestige Consumer Healthcare's Receivables stood at $134.3 million in 2021, then increased by 17.0% to $157.1 million in 2022, then increased by 10.95% to $174.3 million in 2023, then fell by 4.02% to $167.3 million in 2024, then rose by 13.86% to $190.5 million in 2025.
  • The last three reported values for Receivables were $190.5 million (Q4 2025), $199.0 million (Q3 2025), and $168.4 million (Q2 2025) per Business Quant data.